Prime 10 Free On-line Programs in Q1 2023
MyCME, the chief in free medical schooling, gives a bunch of programs throughout all cardiovascular illnesses. Entry the complete library of Cardiology CME and CE without spending a dime.
The highest cardiology CME programs out there now on www.myCME.com embrace matters on mitral stenosis, anemia, cardiac arrhythmia, and extra.
Program Description
Moderated by James A. Underberg, MD, MS, FACP, FNLA and that includes a panel with 4 college audio system (Linda Hemphill, MD, FACC, FNLA, FAHA, Robert Rosenson, MD, Seth Martin, MD, MHS, and Luba Burchett, RN, BSN) this 60 minute webcast will cowl the next data: epidemiology of homozygous familial hypercholesterolemia (HoFH), indicators and signs, prognosis and identification of sufferers with HoFH, screening and genetic exams, at present out there therapy choices for sufferers, present tips for therapy, expertise with evinacumab, navigating the therapy of girls and youngsters, and potential boundaries to therapy.
Academic Aims
Upon completion, contributors ought to have the ability to:
- Establish the indicators, signs, and diagnostic markers of familial hypercholesterolemia
- Describe present tips for the therapy of homozygous familial hypercholesterolemia (HoFH)
- Examine and distinction present therapy choices for HoFH
- Formulate care methods that incorporate affected person wants and potential boundaries to therapy
Supposed Viewers
Cardiologists, lipidologists, internists, major care suppliers, infusion heart nurses, and different healthcare suppliers who deal with sufferers with HoFH.
Industrial Supporter
This exercise is supported by an academic grant from Regeneron Prescription drugs.
Max Credit
- 1.00 / AMA PRA Class 1 Credit score
- 1.00 / ANCC Contact Hour
Expires: April 14, 2023
Program Description
Dr. Tsuyoshi Kaneko lends an skilled perspective on the quickly rising proof base on the function of transcatheter aortic valve alternative (TAVR) in sufferers with bicuspid valve anatomy, together with the newest information introduced on the 2022 annual assembly of the Society of Thoracic Surgeons (STS). Whereas outcomes can rival these seen with conventional surgical valve alternative, Dr. Kaneko notes necessary caveats concerning correct affected person choice that underscore the necessity for evaluation by a coronary heart valve workforce when deciding between the 2 approaches.
Academic Aims
Upon completion, contributors ought to have the ability to:
- Summarize the findings of current information registry analyses in sufferers with bicuspid aortic valves who’ve undergone both surgical or transcatheter aortic valve alternative (SAVR or TAVR)
- Apply these information to the identification of sufferers with bicuspid valve anatomy who would profit from analysis by a coronary heart valve workforce
Supposed Viewers
The audience for this exercise is members of the center valve workforce, together with referring/neighborhood cardiologists, interventional cardiologists, and cardiothoracic surgeons, in addition to major care physicians, nurses, nurse practitioners, doctor associates, and others who look after sufferers with aortic stenosis and bicuspid anatomy.
Industrial Supporter
Supported by an academic grant from Edwards Lifesciences.
Max Credit
- 0.50 / AMA PRA Class 1 Credit score(s)
- 0.50 / ANCC Contact Hour(s)
Expires: April 15, 2023
Program Description
Hypertrophic cardiomyopathy (HCM) is an under-recognized, widespread, and treatable genetic illness occurring worldwide. HCM is a myocardial dysfunction most frequently attributable to mutations in certainly one of a number of sarcomere genes that encode elements of the contractile equipment of the center. It’s characterised by ventricular hypertrophy that can’t be defined by one other cardiac or systemic illness. Including to the burden of illness, HCM can current with a wide range of signs mimicking different circumstances and will go undiagnosed for a few years and it’s estimated that roughly one in 500 people in the USA could have clinically unrecognized, undiagnosed HCM, with an total prevalence estimated at 750,000.
Please be a part of Dr. Maron and Dr. Torres on this first installment of a CMEO Snack collection as they talk about methods for optimum screening of HCM in an effort to extend recognition and prognosis of this too typically misdiagnosed illness.
Academic Aims
Upon completion, contributors ought to have the ability to:
- Assess security and efficacy of rising brokers.
Supposed Viewers
Cardiologists, interventional cardiologists, electrophysiologists, cardiac surgeons (Secondary: Main care physicians/Common practitioners, PAs, nurse practitioners, nurses, and pharmacists).
Industrial Supporter
Supported by an academic grant from Bristol Myers Squibb.
Max Credit
- 0.50 / AMA PRA Class 1 Credit score
- 0.50 / ABIM MOC Level
- 0.50 / AAPA Class 1 CME Credit score
- 0.50 / ANCC Contact Hour
- 0.50 / CE for Pharmacists
Expires: Might 10, 2023
Program Description
Hypertrophic cardiomyopathy (HCM) could be a power, progressive situation wherein sufferers expertise signs of dyspnea, dizziness, and fatigue in addition to critical issues equivalent to coronary heart failure, arrhythmias, stroke, and sudden cardiac loss of life. HCM is a masquerading illness and is well confused with different circumstances. As a result of there are a lot of completely different symptomatic manifestations of HCM, clinicians are usually not at all times updated with evidence-based therapy suggestions, lacking alternatives to supply aid to sufferers with HCM. Observe tips for HCM launched in December 2020 by the AHA/ACC present additional element on when to make use of out there therapy choices. Clinicians want to remain present on the most recent suggestions to arrange to deal with or refer sufferers with HCM to a specialist.
Be a part of Drs. Maron and Olivotto on this 2nd installment of a 3-part CMEO Snack collection on HCM as they establish methods for clinicians to higher implement world and country-specific guideline suggestions to enhance look after sufferers with HCM.
Academic Aims
Upon completion, contributors ought to have the ability to:
- Assess security and efficacy of rising brokers.
Supposed Viewers
Cardiologists, interventional cardiologists, electrophysiologists, cardiac surgeons (Secondary: Main care physicians/Common practitioners, PAs, nurse practitioners, nurses, and pharmacists).
Industrial Supporter
Supported by an academic grant from Bristol Myers Squibb.
Max Credit
- 0.50 / AMA PRA Class 1 Credit score
- 0.50 / ABIM MOC Level
- 0.50 / AAPA Class 1 CME Credit score
- 0.50 / ANCC Contact Hour
- 0.50 / CE for Pharmacists
Expires: Might 10, 2023
Program Description
Hypertrophic cardiomyopathy (HCM) is prevalent all over the world, with a conservatively estimated 20 million people affected. Even in developed nations, present administration of HCM is suboptimal. A lot has been discovered over the previous 2 many years in regards to the pathophysiology of HCM and new therapies equivalent to mavacamten, CK-274, IMB-101, and CT-G20 are at present being developed and examined in scientific trials addressing the underlying pathophysiology of HCM. Though these new brokers are in late phases of growth, clinicians are sometimes not totally updated on this progress and the potential alternative to enhance look after sufferers.
Please be a part of Drs. Maron and Rakowski on this ultimate installment of a CMEO Snack collection on HCM as they talk about strategies to evaluate research outcomes of rising HCM disease-specific therapies focusing on cardiac myosin with the intention to optimize outcomes for sufferers.
Academic Aims
Upon completion, contributors ought to have the ability to:
- Assess research outcomes of rising HCM disease-specific therapies concerning cardiac myosin.
Supposed Viewers
Cardiologists, interventional cardiologists, electrophysiologists, cardiac surgeons (Secondary: Main care physicians/Common practitioners, PAs, nurse practitioners, nurses, and pharmacists).
Industrial Supporter
Supported by an academic grant from Bristol Myers Squibb.
Max Credit
- 0.50 / AMA PRA Class 1 Credit score
- 0.50 / ABIM MOC Level
- 0.50 / AAPA Class 1 CME Credit score
- 0.50 / ANCC Contact Hour
- 0.50 / CE for Pharmacists
Expires: Might 10, 2023
Program Description
Therapy tips embrace suggestions on just lately accepted drugs and discussions of current scientific trial information on monotherapy and mixture therapy choices for pulmonary arterial hypertension (PAH). Present and rising administration methods goal new pathways and therapy targets. This foundational exercise offers nurses with a high-level overview of therapy pathways and therapeutic targets for the administration of PAH.
Academic Aims
Upon completion, contributors ought to have the ability to:
- Assessment the pathophysiology, diagnostic standards, and classification of PAH.
- Establish the courses and related negative effects of medicines used to deal with PAH.
- Summarize new therapy pathways and rising therapeutic targets within the administration of PAH.
- Acknowledge the potential for distant monitoring by way of telehealth in sufferers with PAH.
Supposed Viewers
The meant viewers consists of nurse practitioners, nurses, doctor assistants and different suppliers concerned within the administration of sufferers with PAH.
Industrial Supporter
This exercise is supported by an unbiased medical schooling grant from Actelion Prescription drugs US, Inc., a Janssen Pharmaceutical Firm of Johnson & Johnson.
Max Credit
- 1.00 / AAPA Class 1 CME Credit score
- 1.00 / AANP Contact Hour
- 1.00 / ANCC Contact Hour
Expires: Might 14, 2023
Program Description
On this GapEd Webcast, skilled college audio system Naushira Pandya and Meenakshi Patel will illustrate via affected person instances the significance of individualized A1C objectives and methods on learn how to optimize glycemic management whereas simplifying regimens, minimizing hypoglycemia threat, and enhancing interdisciplinary communication. By this gap-based exercise, learners will have the ability to skip content material they know nicely and think about content material that’s contemplate important by the school, or they’ve a demonstrated hole in data.
Academic Aims
Upon completion, contributors ought to have the ability to:
- Individualize A1C objectives primarily based on patient- and disease-specific components
- Examine and distinction fix-ratio mixtures of GLP-1 RA plus basal insulin with different insulin regimens
- Devise glucose reducing regimens that optimizes high quality of life and glucose management and minimizes hypoglycemia
- Implement methods to enhance interdisciplinary communication and facility care processes to optimize diabetes outcomes
Supposed Viewers
Main Care Physicians, Diabetologists, Endocrinologists, Household Observe Physicians, Household Observe/Common Observe Physicians, Common Observe Physicians, Geriatric Drugs Physicians, Inner Drugs Physicians, Managed Care, Nurse Practitioners, Doctor Assistants, Different healthcare professionals who deal with sufferers with diabetes in a long-term care facility
Industrial Supporter
This exercise is supported by an academic grant from Sanofi US.
Max Credit
- 1.00 / AMA PRA Class 1 Credit score
Expires: Might 15, 2023
Program Description
Dr. Gregory Serrao from Mount Sinai discusses antiplatelet considerations and pharmacodynamics within the context of cardiogenic shock. Subsequent, assessment the trial information, indications, and contraindications on cangrelor introduced by Dr. Jennifer Rymer, MD, from Duke Well being. Moreover, you’ll perceive the optimum “recipe” for antiplatelet administration in HR NSTEMI, STEMI, and cardiogenic shock. Lastly, view a case centered on antiplatelet remedy with cardiogenic shock.
Academic Aims
Upon completion, contributors ought to have the ability to:
- Look at the pharmacokinetic/pharmacodynamic profile of parenteral antiplatelet brokers
- Assessment present information on antiplatelet issues in acute coronary syndrome (ACS) and cardiogenic shock
- Describe up to date antiplatelet therapy protocols in ST-elevation myocardial infarction (STEMI) and cardiogenic shock
- Focus on future antiplatelet and antithrombotic therapeutic targets
Supposed Viewers
Cardiologists
Industrial Supporter
This exercise is supported by an unrestricted academic grant from Chiesi.
Max Credit
- 1.00 / AMA PRA Class 1 Credit score
- 1.00 / ABIM MOC Level
Expires: Might 30, 2023
Program Description
Assessment Proper-Sided mechanical circulatory help (MCS) with RA-PA Pump and Left-Sided MCS with LA-AO Pump. Study extra in regards to the rising function of VA ECMO within the cath lab from Dr. Emmanouil Brilakis. Focus on an summary of biventricular MCS with LA-AO and RA-PA pumps from Dr. Khaldoon Alaswad with Henry Ford Well being and apply the knowledge with a case presentation. Dr. Daniel Burkhoff from CRF and Dr. Rajan Patel average a energetic dialogue.
Academic Aims
Upon completion, contributors ought to have the ability to:
- Assess the implications of proper ventricular (RV) failure in cardiogenic shock
- Focus on the advantages of left atrial-aorta (LA-AO) and proper atrial-pulmonary artery (RA-PA) MCS techniques
- Describe the function of biventricular MCS in treating cardiogenic shock
Supposed Viewers
Cardiologists, Emergency Care Physicians, Hospitalists
Industrial Supporter
This exercise is supported by an academic grant from LivaNova.
Max Credit
- 1.00 / AMA PRA Class 1 Credit score
- 1.00 / ABIM MOC Level
Expires: Might 30, 2023
Program Description
Gentle chain (AL) amyloidosis, a uncommon clonal plasma cell dysfunction characterised by organ deposition of amyloid protein, ends in progressive organ harm that’s normally irreversible. Immediate therapy is important to reaching the very best outcomes, however fast initiation of therapy requires early, correct prognosis, which is commonly delayed due to the nonspecific nature of the signs. Sadly, delayed prognosis is a grave concern, because the median survival price amongst some untreated sufferers is roughly 6 months following symptom onset.
A excessive index of suspicion and applicable testing are wanted to make a prognosis of AL amyloidosis, however the vital delays and a number of doctor visits sufferers sometimes encounter (many sufferers report seeing no less than 5 physicians, together with cardiologists and nephrologists, earlier than receiving a prognosis) point out that clinicians proceed to be confounded by this situation’s extremely variable scientific presentation.
Therapies for AL amyloidosis goal the aberrant plasma/B-cell clone and have historically been primarily based on regimens tailored from the increasing therapy choices out there for a number of myeloma; nonetheless, in January 2021 the FDA accepted a remedy particularly to be used in sufferers with AL amyloidosis.
This exercise encompasses a roundtable dialogue with a multidisciplinary panel of specialists on the most recent data on evidence-based prognosis and therapy tips for sufferers with AL amyloidosis.
Academic Aims
Upon completion, contributors ought to have the ability to:
- Acknowledge the scientific displays that ought to increase suspicion of AL amyloidosis
- Make the most of optimum diagnostic testing to reduce delays in therapy initiation
- Define present and rising therapy choices which can be out there to deal with sufferers with AL amyloidosis, utilizing supporting scientific trial information
Supposed Viewers
This exercise is designed to fulfill the academic wants of hematologist-oncologists, medical oncologists, oncology nurses, cardiologists, nephrologists, and different well being care suppliers concerned within the prognosis and therapy of sufferers with AL amyloidosis.
Industrial Supporter
This exercise is supported by academic grants from The Binding Website and Janssen Biotech Inc., administered by Janssen Scientific Affairs, LLC.
Max Credit
- 1.00 / AMA PRA Class 1 Credit score(s)
- 1.00 / ABIM MOC Half II Factors
- 1.00 / CNE Contact Hour(s)
Expires: June 6, 2023
The Cardiology Advisor Institute, powered by myCme, is a specialty-based neighborhood providing cardiology CE and CME programs, assets, and information tailor-made and curated for you. Specialised matters embrace these and extra:
- Homozygous familial hypercholesterolemia (HoFH)
- Mineralocorticoid receptor antagonists
- Hypertrophic cardiomyopathy (HCM)
- Atrial fibrillation and AFIB therapy
- Excessive-sensitivity cardiac troponin (hs-cTn)
- Transcatheter aortic valve alternative (TAVR)
Ensure that to reap the benefits of this catalog of accredited free cardiology CE and CME programs to your persevering with schooling.
